In This Issue:

Every morning we scan the headlines of the 250+ publicly traded medical technology companies so that you don't have to!

Here are the press categories for today:

Finance

Bausch + Lomb Corporation (BLCO | DoD: -0.26% | YTD: -35.83% | MidCap: 4.1B)

Profile: A leading global eye health company dedicated to helping people see better to live better
Financing: Bausch + Lomb Announces Pricing of Upsized Senior Secured Notes Offering (Full Text)

Insulet Corporation (PODD | DoD: -0.85% | YTD: +17.50% | MidCap: 22.6B)

Profile: The global leader in tubeless insulin pump technology with its Omnipod¬Æ brand of products
Clinical: Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions (Full Text)

Beta Bionics, Inc. (BBNX | DoD: -2.47% | YTD: -24.76% | SmallCap: 810M)

Profile: A commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes
Partnership: Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott's Future Dual Glucose-Ketone Sensor (Full Text)

Lucid Diagnostics Inc. (LUCD | DoD: +2.44% | YTD: +58.69% | SmallCap: 126M)

Profile: A commercial-stage, cancer prevention medical diagnostics company
Product: Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test (Full Text)

Qiagen N.V. (QGEN | DoD: +0.00% | YTD: +4.56% | MidCap: 9.8B)

Profile: Provides sample to insight solutions that transform biological samples into molecular insights
Partnership: QIAGEN and GENCURIX Announce QIAcuity Digital PCR IVD Assay Development Partnership (Full Text)

Castle Biosciences, Inc. (CSTL | DoD: +2.00% | YTD: -32.56% | SmallCap: 468M)

Profile: A company improving health through innovative tests that guide patient care
Announcement: Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Full Text)

Quantum-Si incorporated (QSI | DoD: +4.17% | YTD: -58.92% | SmallCap: 324M)

Profile: A life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS)
Event: Quantum-Si to Join Leading Experts from DNAnexus, Olink, and Northwestern in Upcoming GenomeWeb Webinar on Proteomics Data Integration and Standardization (Full Text)

Johnson & Johnson (JNJ | DoD: -1.08% | YTD: +6.39% | LargeCap: 373.9B)

Profile: Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide
Legal: Johnson & Johnson Hit With $8M Verdict in Massachusetts Mesothelioma Talc Lawsuit (Full Text)